

Is Upneeq in shortage in 2026? Get the latest update on Upneeq availability, pricing, and what patients can do to find it in stock.
If you've been struggling to find Upneeq at your pharmacy, you may be wondering: is Upneeq in shortage? The short answer is no — Upneeq is not currently listed on the FDA Drug Shortage Database. But that doesn't mean it's easy to find.
In this article, we'll give you the latest information on Upneeq availability in 2026, explain why it can be difficult to locate, break down current pricing, and share what you can do to get your prescription filled.
As of early 2026, Upneeq (Oxymetazoline Hydrochloride ophthalmic solution, 0.1%) is not in a formal drug shortage. The FDA Drug Shortage Database does not list Upneeq, and the manufacturer, RVL Pharmaceuticals, continues to produce and distribute the medication.
However, many patients report difficulty finding Upneeq at their local pharmacy. This is a real problem — but it's an availability and distribution issue, not a manufacturing shortage. For a deeper dive into why this happens, read our article on why Upneeq is so hard to find.
There are several reasons Upneeq is difficult to locate, even though it's technically available:
Upneeq is distributed primarily through specialty pharmacies, eye care providers, and aesthetic clinics — not through the standard retail pharmacy supply chain. Most CVS, Walgreens, and Walmart locations do not routinely stock it.
Upneeq treats acquired blepharoptosis (drooping eyelids), which is a real medical condition but affects a smaller population than common conditions like high blood pressure or diabetes. Lower demand means fewer pharmacies carry it.
Many insurance plans don't cover Upneeq, or they require prior authorization. When patients can't afford the cash price, pharmacies may stop stocking it due to low sales volume.
Interest in Upneeq has been growing since its FDA approval in 2020, driven by social media and word-of-mouth. More patients are asking for it, but the supply chain hasn't fully expanded to meet demand at the retail pharmacy level.
Understanding the cost picture is important when navigating availability:
For a full breakdown of ways to save, check out our guide on how to save money on Upneeq in 2026.
As of early 2026, Upneeq remains the only FDA-approved prescription eye drop for acquired blepharoptosis. There is no generic version available. However, there are other approaches patients and doctors can consider:
For more detail on each option, read our article on alternatives to Upneeq.
If you need Upneeq, here are the most effective strategies for finding it:
Medfinder lets you search for pharmacies near you that have Upneeq in stock. It's faster and easier than calling pharmacies one by one.
Many ophthalmologists, optometrists, and oculoplastic surgeons who prescribe Upneeq also dispense it from their office or have preferred specialty pharmacies. Ask your prescriber for recommendations.
Specialty and independent pharmacies are much more likely to carry Upneeq than major chain pharmacies. Search for specialty pharmacies in your area or ask your doctor for a referral.
Telehealth platforms can provide a consultation and ship Upneeq directly to your door. This can be ideal for patients in areas with limited pharmacy options. Learn more in our guide to finding a doctor who can prescribe Upneeq.
Before making a trip to the pharmacy, call ahead or use our guide on checking pharmacy stock to confirm Upneeq is available at your location. This saves time and frustration.
Upneeq is not in shortage, but its limited distribution can make it feel like it is. The key takeaway for 2026: Upneeq is available — you just may need to look beyond your local chain pharmacy to find it.
Use Medfinder to check availability, talk to your eye doctor about where to get it, and explore telehealth options if local access is limited. And if cost is a barrier, don't miss our article on saving money on Upneeq.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.